Can you use NGS panels or ctDNA to help you find organ of origin in the workup of carcinoma of unknown origin?   

If so, what alterations would be helpful to narrow the diagnosis?



Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at FDA U.S. Food and Drug Administration
I wonder what the current evidence supports, the v...
Sign in or Register to read more